Prevalence, Risk Factors, and Treatment Outcomes of Isoniazid- and Rifampicin-Mono-Resistant Pulmonary Tuberculosis in Lima, Peru

Nav

General Info

Geography

Peru (PER)

Lima

Time period covered

01/2010 - 12/2011

Data type

Scientific literature

Keywords

Drug resistance, Mortality, Tuberculosis

Citation

Authors

Villegas L, Otero L, Sterling TR, Huaman MA, Van der Stuyft P, Gotuzzo E, Seas C

Journal

PLoS One

Volume

Issue

Pages

e0152933

Publication year

2016

Suggested citation

Villegas L, Otero L, Sterling TR, Huaman MA, Van der Stuyft P, Gotuzzo E, Seas C. Prevalence, Risk Factors, and Treatment Outcomes of Isoniazid- and Rifampicin-Mono-Resistant Pulmonary Tuberculosis in Lima, Peru. PLoS One. 2016; 11(4): e0152933.

DOI

10.1371/journal.pone.0152933

PMID

27045684

GHDx Entry last modified on: Sep 17, 2024

Header sites

Search form

Main menu

Prevalence, Risk Factors, and Treatment Outcomes of Isoniazid- and Rifampicin-Mono-Resistant Pulmonary Tuberculosis in Lima, Peru

Nav